15/09/2015
Researchers To Help Develop New Treatments For Pancreatic Cancer
Researchers at Queen's University in Belfast are to help develop new treatments for pancreatic cancer.
£2.9 million has been secured under the US-Ireland Research and Development Partnership Programme. It will bring together world-leading experts in drug delivery and cancer research at Queen's, Dublin City University and the University at Buffalo.
The five-year programme will focus on the development of 'nanomedicine' in the treatment of pancreatic cancer, for which current treatment options are limited. The transatlantic team aim to develop miniscule technology – so tiny that it is invisible to the naked eye – to deliver drugs directly to cancer sites and thereby improve the effectiveness of chemotherapy treatments.
In Northern Ireland, during 2009-2013 an average of 220 cases of pancreatic cancer were diagnosed each year. The five-year survival rate for patients diagnosed in 2004-2008 was 5%.
Queen's University Professor Christopher Scott, Director of Research, Molecular Therapeutics Cluster in the School of Pharmacy, who is leading the project, said: "Pancreatic cancer is the fifth most common cause of cancer deaths in the UK. Many chemotherapies could be more effective, and induce fewer side effects, if they could access the tumour more easily; this is what we aim to examine in this project. By working in partnership with researchers in New York and Dublin it will allow us to generate valuable discoveries and innovations which can move our work out of the laboratory and towards clinical trials.
"This is another example of the commitment of researchers and staff at Queen's to advancing knowledge and changing lives."
(CD)
£2.9 million has been secured under the US-Ireland Research and Development Partnership Programme. It will bring together world-leading experts in drug delivery and cancer research at Queen's, Dublin City University and the University at Buffalo.
The five-year programme will focus on the development of 'nanomedicine' in the treatment of pancreatic cancer, for which current treatment options are limited. The transatlantic team aim to develop miniscule technology – so tiny that it is invisible to the naked eye – to deliver drugs directly to cancer sites and thereby improve the effectiveness of chemotherapy treatments.
In Northern Ireland, during 2009-2013 an average of 220 cases of pancreatic cancer were diagnosed each year. The five-year survival rate for patients diagnosed in 2004-2008 was 5%.
Queen's University Professor Christopher Scott, Director of Research, Molecular Therapeutics Cluster in the School of Pharmacy, who is leading the project, said: "Pancreatic cancer is the fifth most common cause of cancer deaths in the UK. Many chemotherapies could be more effective, and induce fewer side effects, if they could access the tumour more easily; this is what we aim to examine in this project. By working in partnership with researchers in New York and Dublin it will allow us to generate valuable discoveries and innovations which can move our work out of the laboratory and towards clinical trials.
"This is another example of the commitment of researchers and staff at Queen's to advancing knowledge and changing lives."
(CD)
Related Northern Ireland News Stories
Click here for the latest headlines.
22 May 2019
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
07 November 2008
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
07 April 2004
Health meeting to tackle cancer scourge
Northern Ireland's Chief Medical Officer today met with leading figures from the American Cancer Society to discuss how cancer prevention, treatment and research could be benefited from greater collaboration. Dr Henrietta Campbell said today's meeting was one of the significant benefits arising from the American/All-Ireland Cancer Consortium.
Health meeting to tackle cancer scourge
Northern Ireland's Chief Medical Officer today met with leading figures from the American Cancer Society to discuss how cancer prevention, treatment and research could be benefited from greater collaboration. Dr Henrietta Campbell said today's meeting was one of the significant benefits arising from the American/All-Ireland Cancer Consortium.
10 April 2014
Stormont Group Says More Cancer Could Be Prevented
Almost 12,800 people in Northern Ireland are diagnosed with cancer each year and a significant number of these could be prevented through greater awareness, a new report from the All Party Group on Cancer (APGC) at Stormont has revealed.
Stormont Group Says More Cancer Could Be Prevented
Almost 12,800 people in Northern Ireland are diagnosed with cancer each year and a significant number of these could be prevented through greater awareness, a new report from the All Party Group on Cancer (APGC) at Stormont has revealed.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.